Virios Therapeutics Inc/$DWTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Virios Therapeutics Inc
Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.
Ticker
$DWTX
Sector
Primary listing
Employees
8
Headquarters
Website
DWTX Metrics
BasicAdvanced
$50m
-
-$2.18
1.70
-
Price and volume
Market cap
$50m
Beta
1.7
52-week high
$9.50
52-week low
$1.28
Average daily volume
92k
Financial strength
Current ratio
5.861
Quick ratio
5.167
Long term debt to equity
0.109
Total debt to equity
0.18
Profitability
EBITDA (TTM)
-28.61
Effective tax rate (TTM)
-0.11%
Management effectiveness
Return on assets (TTM)
-18.60%
Return on equity (TTM)
-34.67%
Valuation
Price to book
0.62
Price to tangible book (TTM)
0.73
Price to free cash flow (TTM)
-1.248
Free cash flow yield (TTM)
-80.12%
Free cash flow per share (TTM)
-1.194
Growth
Earnings per share change (TTM)
-87.91%
3-year earnings per share growth (CAGR)
-50.60%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs